medication for type 2 diabetes, withdrawn due to liver toxicity
Troglitazone, also known as Rezulin, is a medication that was used to treat type 2 diabetes by improving insulin sensitivity. However, it was withdrawn from the market due to severe liver toxicity and associated health risks.
— no results